Editorial Staff

  • Clinical Editor:

    Morton Kern, MD
  • Executive Editor:

    Laurie Gustafson
  • Managing Editor:

    Rebecca Kapur
  • Production Manager:

    Elizabeth Vasil
  • Editorial Correspondence

  • Rebecca Kapur, Managing Editor, Cath Lab Digest
  • HMP Communications, 83 General Warren Blvd

    Suite 100, Malvern PA 19355
  • Telephone: (800) 459-8657

    Fax: (866) 896-8762
  • Email: rkapur@hmpcommunications.com
  • March 2017
    |
    Volume 25
    Issue 3

    Morton Kern, MD
    Clinical Editor; Chief of Medicine, 
    Long Beach Veterans 
    Administration Health Care 
    System, Long Beach, California; 
    Associate Chief Cardiology, 
    Professor of Medicine, University of California Irvine, Orange, California
    mortonkern2007@gmail.com

    We prescribe these drugs to reduce the rates of stent-related thrombosis in both the short and long term, and we must weigh the risk of stent thrombosis against the risk of bleeding. This balancing act is not always straightforward.

    continue reading
    Volume 25 - Issue 3 - March 2017   |   2,081 reads

    Cath Lab Digest talks with Ramon L. Varcoe, MBBS, MS, PhD, FRACS, 
    Associate Professor of Vascular Surgery, University of New South Wales; 
    Vascular Surgeon, Prince of Wales Hospital, Sydney, Australia.

    From the VEITH Symposium, November 15-19, 2016, New York, New York. 

    This was a first-in-human study. We began working with this new investigational device approximately four years ago. The study itself was a single-center study and is a prospective cohort that we have been performing for slightly less than four years now. Currently, it stands at 49 treated limbs, representing 44 patients, and with a total of 65 bioresorbable scaffolds used.

    continue reading
    Volume 25 - Issue 3 - March 2017   |   1,012 reads

    Mary Farley, RN, BSN, Nurse Manager Invasive Cardiology
    Alon Yarkoni, MD, FACC, Director, Structural Heart Program 
    Johnson City, New York

    We recently renovated and expanded one cath and EP lab. The cath lab was built for use as a hybrid interventional lab, and in both rooms, we installed state-of-the-art equipment.

    continue reading
    Volume 25 - Issue 3 - March 2017   |   1,970 reads

    Michael Seymour, MS, MPH, CIH, Organization for Occupational Radiation Safety in Interventional Fluoroscopy (ORSIF), Washington, D.C.

    Over the past several years, a spate of scientific evidence has demonstrated the health risks that interventional teams incur while performing life-saving minimally invasive procedures. The health effects range from skin erythema to premature aging (cataracts, reduced cognitive function, etc.), to cancer.

    continue reading
    Volume 25 - Issue 3 - March 2017   |   10,506 reads

    Adam T. Stys MD, FACC, Muhammad A. Khan, MD, Naveen Rajpurohit, MD, Tomasz P. Stys, MD, FACC, Sanford Cardiovascular Institute, University of South Dakota, Sanford School of Medicine, Sioux Falls, South Dakota

    We present a novel technique of extreme PCI support, as depicted in our case series, which allowed completion of PCI otherwise not possible by using conventional means. We describe a triple telescopic system, involving a smaller in a larger GuideLiner catheter (Vascular Solutions) in a large guide catheter.

    continue reading
    Volume 25 - Issue 3 - March 2017   |   1,668 reads

    Gary Clifton, Vice President, Terumo Business Edge, talks with Amit P. Amin, MD, MSc, Washington University School of Medicine, Barnes Jewish Hospital, Center for Value and Innovation, Washington University School of Medicine, St. Louis, Missouri.

    Despite tremendous improvements in PCI devices, technology and pharmacotherapy, we have not yet streamlined care pathways to mirror these technological advancements. Thus, the current care pathways are leading to unnecessary high costs of care. If we (the cath lab staff and interventional community) optimized the care pathway, it would lead to tremendous economic advantages while preserving or even improving PCI outcomes and patient satisfaction. 

    continue reading
    Volume 25 - Issue 3 - March 2017   |   1,512 reads

    Jackson Thatcher, MD, FACC, FSCAI, St. Cloud VA Healthcare System, 
    St. Cloud, Minnesota

    In interventional cardiology, we are constantly forced to address real-life questions as to when, and not infrequently, when not to intervene. We must always remember that cath-stent is an unnatural reflex, which should also indicate “caution”.

    continue reading
    Volume 25 - Issue 3 - March 2017   |   706 reads

    Brijeshwar S. Maini, MD, Clinical Professor of Medicine, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida; Regional Medical Director of Transcatheter Therapies, Tenet Healthcare Corporation, Eastern Region - Coastal Division, Miguel A. Diaz, MD, Director, Interventional Cardiology Fellowship Program, Brian Valle, DO, Palmetto General Hospital, Hialeah, Florida

    Here we present a case of severe degenerative MR with complex anatomy that was initially treated using the first-generation MitraClip device, resulting in an single leaflet device attachment (SLDA) of the second MitraClip. The patient later returned for successful treatment using the MitraClip NT device, marking the first commercial use of this product in South Florida.

    continue reading
    Volume 25 - Issue 3 - March 2017   |   2,023 reads